Influenza virus and glycemic variability in diabetes: A killer combination?

Frontiers in Microbiology

Volumn 8, Issue MAY, 2017, Pages

  Hulme, Katina D ^a   Gallo, Linda A ^a   Short, Kirsty R ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Diabetes; Glucose; Glycemic oscillations; Hyperglycemia; Influenza

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH MOBILITY GROUP B1 PROTEIN;

ARTICLE; BACTERIAL INFECTION; BLINDNESS; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; END STAGE RENAL DISEASE; ENDOTHELIUM CELL; GENE OVEREXPRESSION; GLYCEMIC INDEX; HUMAN; HYPERGLYCEMIA; IMMUNE DEFICIENCY; INFLUENZA; INFLUENZA VIRUS; INSULIN RESISTANCE; LIMB AMPUTATION; LUNG FUNCTION; NONHUMAN; OSCILLATION; PATHOGENESIS; RESPIRATORY FUNCTION; VASCULAR DISEASE; VIRUS INFECTION;

EID: 85019748759     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2017.00861     Document Type: Article

References (65)

1. Alexiewicz, J. M., Kumar, D., Smogorzewski, M., Klin, M., and Massry, S. G. (1995). Polymorphonuclear leukocytes in non-insulin-dependent diabetes mellitus: abnormalities in metabolism and function. Ann. Intern. Med. 123, 919-924. doi: 10.7326/0003-4819-123-12-199512150-00004
2. Allard, R., Leclerc, P., Tremblay, C., and Tannenbaum, T.-N. (2010). Diabetes and the severity of pandemic influenza A (H1N1) infection. Diabetes Care 33, 1491-1493. doi: 10.2337/dc09-2215
3. Azuma, K., Kawamori, R., Toyofuku, Y., Kitahara, Y., Sato, F., Shimizu, T., et al. (2006). Repetitive fluctuations in blood glucose enhance monocyte adhesion to the endothelium of rat thoracic aorta. Arterioscler. Thromb. Vasc. Biol. 26, 2275-2280. doi: 10.1161/01.ATV.0000239488.05069.03
4. Barrau, M., Larrieu, S., Cassadou, S., Chappert, J. L., Dussart, P., Najioullah, F., et al. (2012). Hospitalized cases of influenza A(H1N1)pdm09 in the French territories of the Americas, July 2009-March 2010. Pan Am. J. Public Health 32, 124-130. doi: 10.1590/S1020-49892012000800006
5. Bonora, E., and Muggeo, M. (2001). Postprandial blood glucose as a risk factor for cardiovascular disease in type II diabetes: the epidemiological evidence. Diabetologia 44, 2107-2114. doi: 10.1007/s001250100020
6. Campbell, A., Rodin, R., Kropp, R., Mao, Y., Hong, Z., Vachon, J., et al. (2010). Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza. CMAJ 182, 349-355. doi: 10.1503/cmaj.091823
7. Ceriello, A., Esposito, K., Piconi, L., Ihnat, M. A., Thorpe, J. E., Testa, R., et al. (2008). Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes Metab. Res. Rev. 57, 1349-1354. doi: 10.2337/db08-0063
8. Cortes, G. M., Sierra Moros, M. J., Santa-Olalla Peralta, P., Hernandez-Barrera, V., Jimenez-Garcia, R., and Pachon, I. (2011). Clinical characteristics and outcomes of diabetes sufferers hospitalized from 2009 pandemic influenza A H1N1 infections. J. Infect. 64, 218-224. doi: 10.1016/j.jinf.2011.11.022
9. Davies, M. (2004). The reality of glycaemic control in insulin treated diabetes: defining the clinical challenges. Int. J. Obes. Relat. Metab. Disord. 28, S14-S22. doi: 10.1038/sj.ijo.0802745
10. Diepersloot, R., Bouter, K., Beyer, W., Hoekstra, J., and Masurel, N. (1987). Humoral immune response and delayed type hypersensitivity to influenza vaccine in patients with diabetes mellitus. Diabetologia 30, 397-401. doi: 10.1007/BF00292541
11. Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., et al. (2009). Glucose control and vascular complications in veterans with type 2 diabetes. N. Engl. J. Med. 360, 129-139. doi: 10.1056/NEJMoa0808431
12. Gallo, L. A., Wright, E. M., and Vallon, V. (2015). Probing SGLT2 as a therapeutic target for diabetes: basic physiology and consequences. Diabetes Vasc. Dis. Res. 12, 78-89. doi: 10.1177/1479164114561992
13. Garcia, M. N., Philpott, D. C., Murray, K. O., Ontiveros, A., Revell, P. A., Chandramohan, L., et al. (2015). Clinical predictors of disease severity during the 2009-2010 A(HIN1) influenza virus pandemic in a paediatric population. Epidmiol. Infect. 143, 2939-2949. doi: 10.1017/S0950268815000114
14. Garnett, J. P., Baker, E. H., Naik, S., Lindsay, J. A., Knight, G. M., Gill, S., et al. (2013). Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose. Thorax 68, 835-845. doi: 10.1136/thoraxjnl-2012-203178
15. Gilca, R., De Serres, G., Boulianne, N., Ouhoummane, N., Papenburg, J., Douville-Fradet, M., et al. (2011). Risk factors for hospitalization and severe outcomes of 2009 pandemic H1N1 influenza in Quebec, Canada. Influenza Other Respir. Viruses 5, 247-255. doi: 10.1111/j.1750-2659.2011.00204.x
16. Guja, C., Ionescu-Tirgoviste, C., Fica, S., Sabau, S., Radu, S., Micu, A., et al. (2011). Improvements in life expectancy in adult type 2 diabetes patients in the last six decades. Diabetes Res. Clin. Pract. 92, 400-404. doi: 10.1016/j.diabres.2011.03.022
17. Hanslik, T., Boelle, P. Y., and Flahault, A. (2010). Preliminary estimation of risk factors for admission to intensive care units and for death in patients infected with A(H1N1)2009 influenza virus, France, 2009-2010. PLoS Curr. 2:RRN1150. doi: 10.1371/currents.RRN1150
18. Hayer, M. K., Farrugia, D., Begaj, I., Ray, D., and Sharif, A. (2014). Infection-related mortality is higher for kidney allograft recipients with pretransplant diabetes mellitus. Diabetologia 57, 554-561. doi: 10.1007/s00125-013-3124-5
19. Hirakawa, Y., Arima, H., Zoungas, S., Ninomiya, T., Cooper, M., Hamet, P., et al. (2014). Impact of visit-to-visit glycemic variability on the risk of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial. Diabetes Care 37, 2358-2365. doi: 10.2337/dc14-0199
20. Huo, L., Harding, J. L., Peeters, A., Shaw, J. E., and Magliano, D. J. (2016). Life expectancy of type 1 diabetic patients during 1997-2010: a national Australian registry-based cohort study. Diabetologia 59, 1177-1185. doi: 10.1007/s00125-015-3857-4
21. Ilyas, R., Wallis, R., Soilleux, E. J., Townsend, P., Zehnder, D., Tan, B. K., et al. (2011). High glucose disrupts oligosaccharide recognition function via competitive inhibition: a potential mechanism for immune dysregulation in diabetes mellitus. Immunobiology 216, 126-131. doi: 10.1016/j.imbio.2010.06.002
22. International Diabetes Federation (2015). IDF Diabetes Atlas. Brussels: International Diabetes Federation.
23. Ito, M., Kubota, H., Takeuchi, T., Qiao, S., Tsurudome, M., Tsumura, H., et al. (2015). Pathogenesis of the influenza virus in diabetes model mice. Br. Microbiol. Res. J. 9, 1-7. doi: 10.9734/BMRJ/2015/18799
24. Jiménez-García, R., Hernández-Barrera, V., Rodríguez-Rieiro, C., Lopez De Andres, A., De Miguel-Diez, J., Jimenez-Trujillo, I., et al. (2013). Hospitalizations from pandemic Influenza [A(H1N1)pdm09] infections among type 1 and 2 diabetes patients in Spain. Influenza Other Respir. Viruses 7, 439-447. doi: 10.1111/j.1750-2659.2012.00419.x
25. Kohio, H. P., and Adamson, A. L. (2013). Glycolytic control of vacuolar-type ATPase activity: a mechanism to regulate influenza viral infection. Virology 444, 301-309. doi: 10.1016/j.virol.2013.06.026
26. Kumar, A., Zarychanski, R., Pinto, R., Cook, D. J., Marshall, J., Lacroix, J., et al. (2009). Critically ill patients with 2009 influenza A (H1N1) infection in Canada. JAMA 302, 1872-1879. doi: 10.1001/jama.2009.1496
27. Lange, P., Groth, S., Kastrup, J., Mortensen, J., Appleyard, M., Nyboe, J., et al. (1989). Diabetes mellitus, plasma glucose and lung function in a cross-sectional population study. Eur. Respir. J. 2, 14-19.
28. Lenzi, L., Melloâ. M., Silva, L. R., Grochocki, M. H., and Pontarolo, R. (2012). Pandemic influenza A (H1N1) 2009: risk factors for hospitalization. J. Bras. Pneumol. 38, 57-65. doi: 10.1590/S1806-37132012000100009
29. Leung, C. C., Lam, T. H., Chan, W. M., Yew, W. W., Ho, K. S., Leung, G. M., et al. (2008). Diabetic control and risk of tuberculosis: a cohort study. Am. J. Epidemiol. 167, 1486-1494. doi: 10.1093/aje/kwn075
30. Lin, Y.-T., Wang, F.-D., Wu, P.-F., and Fung, C.-P. (2013). Klebsiella pneumoniae liver abscess in diabetic patients: association of glycemic control with the clinical characteristics. BMC Infect. Dis. 13:56. doi: 10.1186/1471-2334-13-56
31. Lutgers, H. L., Gerrits, E. G., Sluiter, W. J., Ubink-Veltmaat, L. J., Landman, G. W., Links, T. P., et al. (2009). Life expectancy in a large cohort of type 2 diabetes patients treated in primary care (ZODIAC-10). PLoS ONE 4:e6817. doi: 10.1371/journal.pone.0006817
32. Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J.-P., et al. (2006). Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295, 1681-1687. doi: 10.1001/jama.295.14.1681
33. Morgan, O. W., Bramley, A., Fowlkes, A., Freedman, D. S., Taylor, T. H., Gargiullo, P., et al. (2010). Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A (H1N1) disease. PLoS ONE 5:e9694. doi: 10.1371/journal.pone.0009694
34. Mudaliar, H., Pollock, C., Ma, J., Wu, H., Chadban, S., and Panchapakesan, U. (2014). The role of TLR2 and 4-mediated inflammatory pathways in endothelial cells exposed to high glucose. PLoS ONE 9:e108844. doi: 10.1371/journal.pone.0108844
35. Perrone, L. A., Plowden, J. K., García-Sastre, A., Katz, J. M., and Tumpey, T. M. (2008). H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog. 4:e1000115. doi: 10.1371/journal.ppat.1000115
36. Philips, B. J., Meguer, J.-X., Redman, J., and Baker, E. H. (2003). Factors determining the appearance of glucose in upper and lower respiratory tract secretions. Intensive Care Med. 29, 2204-2210. doi: 10.1007/s00134-003-1961-2
37. Popov, D., and Simionescu, M. (1997). Alterations of lung structure in experimental diabetes, and diabetes associated with hyperlipidaemia in hamsters. Eur. Respir. J. 10, 1850-1858. doi: 10.1183/09031936.97.10081850
38. Quagliaro, L., Piconi, L., Assaloni, R., Da Ros, R., Maier, A., Zuodar, G., et al. (2005). Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production. Atherosclerosis 183, 259-267. doi: 10.1016/j.atherosclerosis.2005.03.015
39. Quagliaro, L., Piconi, L., Assaloni, R., Martinelli, L., Motz, E., and Ceriello, A. (2003). Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells the role of protein kinase C and NAD (P) H-oxidase activation. Diabetes Metab. Res. Rev. 52, 2795-2804. doi: 10.2337/diabetes.52.11.2795
40. Rayfield, E. J., Ault, M. J., Keusch, G. T., Brothers, M. J., Nechemias, C., and Smith, H. (1982). Infection and diabetes: the case for glucose control. Am. J. Med. 72, 439-450. doi: 10.1016/0002-9343(82)90511-3
41. Reading, P. C., Allison, J., Crouch, E. C., and Anders, E. M. (1998). Increased susceptibility of diabetic mice to influenza virus infection: compromise of collectin-mediated host defense of the lung by glucose? J. Virol. 72, 6884-6887.
42. Risso, A., Mercuri, F., Quagliaro, L., Damante, G., and Ceriello, A. (2001). Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. Am. J. Physiol. Endocrinol. Metab. 281, E924-E930.
43. Rollins, K. E., Varadhan, K. K., Dhatariya, K., and Lobo, D. N. (2016). Systematic review of the impact of HbA1c on outcomes following surgery in patients with diabetes mellitus. Clin. Nutr. 35, 308-316. doi: 10.1016/j.clnu.2015.03.007
44. Saisho, Y. (2014). Glycemic variability and oxidative stress: a link between diabetes and cardiovascular disease? Int. J. Mol. Sci. 15, 18381-18406. doi: 10.3390/ijms151018381
45. Shirey, K. A., Lai, W., Scott, A. J., Lipsky, M., Mistry, P., Pletneva, L. M., et al. (2013). The TLR4 antagonist Eritoran protects mice from lethal influenza infection. Nature 497, 498-502. doi: 10.1038/nature12118
46. Short, K. R., Habets, M. N., Hermans, P. W., and Diavatopoulos, D. A. (2012). Interactions between Streptococcus pneumoniae and influenza virus: a mutually beneficial relationship? Future Microbiol. 7, 609-624. doi: 10.2217/fmb.12.29
47. Short, K. R., Kasper, J., van der Aa, S., Andeweg, A. C., Zaaraoui-Boutahar, F., Goeijenbier, M., et al. (2016). Influenza virus damages the alveolar barrier by disrupting epithelial cell tight junctions. Eur. Respir. J. 47, 954-966. doi: 10.1183/13993003.01282-2015
48. Short, K. R., Kroeze, E. J. V., Fouchier, R. A., and Kuiken, T. (2014). Pathogenesis of influenza-induced acute respiratory distress syndrome. Lancet Infect. Dis. 14, 57-69. doi: 10.1016/S1473-3099(13)70286-X
49. Short, K. R., Richard, M., Verhagen, J. H., van Riel, D., Schrauwen, E. J., van den Brand, J. M. A., et al. (2015). One health, multiple challenges: the inter-species transmission of influenza A virus. One Health 1, 1-13. doi: 10.1016/j.onehlt.2015.03.001
50. Short, K. R., Veldhuis Kroeze, E. J., Reperant, L. A., Richard, M., and Kuiken, T. (2013). Influenza virus and endothelial cells: a species specific relationship. Front. Microbiol. 5:653. doi: 10.3389/fmicb.2014.00653
51. Stegenga, M. E., van der Crabben, S. N., Blümer, R. M., Levi, M., Meijers, J. C., Serlie, M. J., et al. (2008). Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia. Blood 112, 82-89. doi: 10.1182/blood-2007-11-121723
52. Teijaro, J. R., Walsh, K. B., Cahalan, S., Fremgen, D. M., Roberts, E., Scott, F., et al. (2011). Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell 146, 980-991. doi: 10.1016/j.cell.2011.08.015
53. The Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein, H. C., Miller, M. E., Byington, R. P., Goff, D. C. Jr., Bigger, J. T., et al. (2008). Effects of intensive glucose lowering in type 2 diabetes. N. Engl. J. Med. 358, 2545-2559. doi: 10.1056/NEJMoa0802743
54. The Advance Collaboration group (2008). Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N. Engl. J. Med. 358, 2560-2572. doi: 10.1056/NEJMoa0802987
55. The Emerging Risk Factors Collaboration (2011). Diabetes mellitus, fasting glucose, and risk of cause-specific death. N. Engl. J. Med. 2011, 829-841. doi: 10.1056/NEJMoa1008862
56. The U.K. Prospective Diabetes Study Group (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352, 837-853. doi: 10.1016/S0140-6736(98)07019-6
57. Valdez, R., Narayan, K., Geiss, L., and Engelgau, M. (1999). Impact of diabetes mellitus on mortality associated with pneumonia and influenza among non-Hispanic Black and White US adults. Am. J. Public Health 89, 1715-1721. doi: 10.2105/AJPH.89.11.1715
58. Venkata, C., Sampathkumar, P., and Afessa, B. (2010). Hospitalized Patients with 2009 H1N1 influenza infection: the mayo clinic experience. Mayo Clin. Proc. 85, 798-805. doi: 10.4065/mcp.2010.0166
59. Vos, T., Barber, R. M., Bell, B., Bertozzi-Villa, A., Biryukov, S., Bolliger, I., et al. (2015). Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386, 743-800. doi: 10.1016/S0140-6736(15)60692-4
60. Wilking, H., Buda, S., von der Lippe, E., Altmann, D., Krause, G., Eckmanns, T., et al. (2010). Mortality of 2009 pandemic influenza A (H1N1) in Germany. Euro Surveill. 15:19741.
61. Wiwanitkit, V. (2008). Hyperglycemia in the recent reported cases of bird flu infection in Thailand and Vietnam. J. Diabetes Complications 22:76. doi: 10.1016/j.jdiacomp.2006.05.007
62. Wu, J., Zhang, F., Fang, F., Chang, H., Wang, F., Yang, Z., et al. (2010). Efficacy of inactivated vaccine against H5N1 influenza virus infection in mice with type 1 diabetes. Vaccine 28, 2775-2781. doi: 10.1016/j.vaccine.2010.01.037
63. Xi, X., Jiang, L., Xu, Y., Li, A., Duan, J., and Du, B. (2010). Hospitalized adult patients with 2009 influenza A(H1N1) in Beijing, China: risk factors for hospital mortality. BMC Infect. Dis. 10:256. doi: 10.1186/1471-2334-10-256
64. Yeh, H.-C., Punjabi, N. M., Wang, N.-Y., Pankow, J. S., Duncan, B. B., Cox, C. E., et al. (2008). Cross-sectional and prospective study of lung function in adults with type 2 diabetes. Diabetes Care 31, 741-746. doi: 10.2337/dc07-1464
65. Zhu, Q., Chang, H., Chen, Y., Fang, F., Xue, C., Zhang, F., et al. (2005). Protection of inactivated influenza virus vaccine against lethal influenza virus infection in diabetic mice. Biochem. Biophys. Res. Commun. 329, 87-94. doi: 10.1016/j.bbrc.2005.01.109